A Solitary Fibrous Tumor in the Pancreas.
Chen Jing-wen,Lu Tao,Liu Hou-bao,Tong Sai-xiong,Ai Zhi-long,Suo Tao,Ji Yuan
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20111740
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Solitary fibrous tumors (SFTs), which are mostly found in the pleura, have been increasingly described in almost every anatomical location of the body. However, reports of these tumors in the pancreas are still rare. We present a case of SFT in the pancreas and review the clinical characteristics of these 10 cases. A 49-year-old woman presented with a 1-month history of mild pain in the upper abdomen, especially after meals. The patient complained of increasingly greater abdominal distension and a loss of appetite. No jaundice or other symptoms of obstruction were found. A soft fixed mass was palpable in the right upper quadrant without pain. The patient had never suffered from hypoglycemia and the fasting blood-glucagon was within normal levels. Serum laboratory results and tumor markers (AFP, CEA, CA19-9 and CA125) were also within normal limits. A contrast-enhanced CT scan revealed a 13 cm×10 cm×10 cm different-density soft-tissue mass in the right upper quadrant, in close relation to the head of the pancreas, with a partially hypo-dense region in the cystic area. The mass showed a mild enhancement in the arterial phase and progressive enhancement in the portal phase. In CTA imaging, the mass surrounded the celiac trunk, the common hepatic artery and pancreatic duodenal arteries, and compressed the portal vein and the superior mesenteric vein, and inferior vena cava as well. A total body scan showed no distant metastasis. Fine needle aspiration was done, resulting in a mesenchymal tumor composed of short spindle cells. A Whipple/Child procedure was performed to explore an expansive-growth mass in the head of pancreas, which separated the common bile duct and the common hepatic artery. The operation risked damaging the common bile duct before revealing the portal vein. The excised potion of the pancreas contained a 13 cm×13 cm×8 cm well-circumscribed, non-encapsulated, grayish-white mass with areas of necrosis in black. Histologic evaluation showed a lesion composed of spindle cells with hypercellular areas. The diagnosis was supported by immunohistochemical studies showing positive results for vimentin, muscle-specific actin (MSA), CD68, CD34, Bcl-2 and K°67, and negative results for cytokeratin (CK), smooth muscle actin (SMA), desmin, CD117, CD99 and S-100 (Figure 1). A post-operative thirty-month follow-up showed no recurrence or complication.Figure 1.: Axial arterial phase (A), portal phase (B) CT images show well-defined, lobulated mass in close relation to the head of the pancreas. The mass showed progressive enhancement from arterial phase to portal venous phase with a partly hypo-dense region in the cystic area. Coronary reformatted images with artery (C) and portal vein (D) show the relationship of the blood vessels. The mass surrounds the celiac trunk, common hepatic artery and pancreaticoduodenal artery and compressed the portal vein, superior mesenteric vein and inferior vena cava. E: Resection specimen demonstrated a 13 cm×13 cm×8 cm circumscribed non-encapsulated mass present in the head of the pancreas. F: The tumor shows a patternless arrangement with abnormal vessels (HE, original magnification ×100). G: The tumor shows compact, interlacing short spindle-shaped cells with diffuse keloidal-like, hyalinized collagen (HE, original magnification ×400). H: The spindle cells show diffuse positive stains for Bcl-2 (immunohistochemical staining, original magnification ×100). I: The spindle cells show diffuse strongly positive stains for CD34 (immunohistochemical staining, original magnification ×200).Solitary fibrous tumors are rare neoplasms that most commonly occur in the visceral pleura. In fact, about 65% of SFTs arise from the pleura.1 Extrapleural solitary fibrous tumors, especially those found in the pancreas, represent a rare type of soft tissue neoplasm. The first case of SFT in the pancreas was reported by Adachi in 1999/2 Only nine cases have been found primarily in the pancreas. Eight of the ten patients were females, and their ages ranged from 41 to 78. All lesions had occurred in the head and/or body of the pancreas and ranged in size from 2 to 13 cm. Five cases were found incidentally and the other five were associated with atypical abdominal pain and weight loss. There was no jaundice or hypoglycemia reported in these cases. A diagnosis prior to surgery relies most often upon the imaging examinations. In our case, the CT scan showed a neoplasm with a contrast enhancement during both the arterial and venous phases, suggesting an endocrine neoplasm or solid pseudopapillary tumor. No pancreatic duct obstructions were found in the ten cases. SFT mostly manifests as a well-defined, solid pancreatic tumor with cystic portions. It is difficult to distinguish an SFT from a non-functioning islet tumor or solid pseudopapillary tumor of the pancreas. In our case, CT imaging showed that the tumor surrounded adjacent arteries and compressed key veins in nearby organs. Fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT showed no significant FDG uptake. The cell block preparation showed bland-appearing spindle cells, which indicated diagnosis of a benign mesenchymal tumor prior to operation. But the practice is not recommended. A very small area of the tumor is obtained during a biopsy while malignant foci may be missed, leading to a falsely positive result. Moreover, percutaneous biopsy may risk seeding tumor cells along the biopsy tract.3 Radical excision is the best treatment for SFTs, by far. They are readily curable with careful, complete resections. Due to the rarity of these tumors, reports of adjuvant therapy are inadequate to draw a conclusion. Grossly, SFT in the pancreas shows a firm, circumscribed mass with a characteristic whorled appearance. The size varies from 1.5 to 13 cm in diameter. Microscopically, SFT shows a benign appearance in most cases; however, it shows considerable invasion of the pancreatic parenchyma in some cases, indicating more aggressive behavior.2 Immunohistochemistry is quite useful in differentiating SFT from other lesions in the pancreas.4 CD34, Bcl-2 and vimentin were strongly stained in most pathological sections. CD99 was strongly stained in the previous nine cases but was negative in the present one. Smooth muscle actin and CD117 were only stained in the focal area of some cases, while S-100 was negative in all cases. Both primary and secondary lesions to the pancreas could be considered in an initial diagnosis. Application of appropriate immunohistochemistry can resolve any doubt in difficult cases. Primary pancreatic leiomyosarcoma (LMS) is a rare malignant neoplasm. Abdominal pain, weight loss, epigastric tenderness and abdominal mass are the most common symptoms. The size of LMS ranges from 3 to 25 cm. LMS presents as spindle cell neoplasm, which shows mild to moderate nuclear pleomorphism and anisocytosis.5 Only six cases of primary gastrointestinal stromal tumors (GIST) in the pancreas have been reported. But secondary GIST involving the pancreas presents with pseudocystic change and mimics pancreatic tumors.6 Solid pseudopapillary tumors of the pancreas (SPTP) are rare, usually affecting young women. SPTP is well-encapsulated, while SFT is usually un-encapsulated. But a thin envelop can be seen in the radiograph of the large SFT, because of the compression of the adjacent tissue. SPTP contains a mixture of solid, cystic, and pseudopapillary patterns in various proportions.7 Endocrine tumors of the pancreas (PETs), especially the non-functioning islet tumors, are clinically and histologically similar to SFTs. Most PETs are characterized with a tumor separated from the normal pancreas by a complete or incomplete fibrous capsule, never invading the peripancreatic vessels.8 SFTs in pleura show 80% benign cases and permit long-term survival, even in 70% recurring cases.1 In our case, no recurrence could be found after surgery and the patient was alive and well after a thirty-month follow-up.